A best practice in CSU resource.

Novartis collaborated with five experts in the field of CSU to create this platform to share individual best practice and ways of working with the wider medical community. The articles presented in this guide are intended as tools and guidance to help effectively diagnose and manage patients with CSU. 

View the full best practice booklet.


As part of our mission to be as environmentally friendly as possible, we provide our resources in electronic form. These materials should not be printed by healthcare professionals.


CSU, chronic spontaneous urticaria.


Rate this content: 
No votes yet
XSU20-C022 July 2020.

Ask Speakers


Medical Information Request

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis via [email protected] or online through the pharmacovigilance intake (PVI) tool at www.report.novartis.com
If you have a question about the product, please contact Medical Information on 01276 698370 or by email at [email protected]